Medical Devices Startups

EpiEP develops the EpiAccess System, a pressure-guided needle used with standard fluoroscopy to give physicians real-time confirmation of access into the pericardial cavity for epicardial heart procedures. The technology supports treatments such as ventricular tachycardia, atrial fibrillation, and left atrial appendage ligation, and serves cardiac electrophysiologists and interventional cardiologists.

1 investor

A company bringing together expertise in genetics, pathology, medicine, and bioinformatics to develop data science and AI solutions in the healthcare field.

1 investor

Epinoma develops EpiAmp, a methyl-preserving amplification technology to analyze epigenetic changes and methylation patterns for applications in disease detection, drug development, and patient stratification. The company serves research institutions, pharmaceutical companies, and clinical diagnostic organizations in the biotech and healthcare sectors.

1 investor

Epitomee Medical develops the Epitomee Capsule, a medical device for weight management solutions. The company brings together experts in medical technology and clinical research to address health outcomes.

1 investor

An integrated discovery platform for rapidly identifying high-quality VHH lead molecules from humanized libraries using cDNA display technology and developability assessment for drug research programs.

1 investor

EPTAM provides precision machining, plastics, and molding manufacturing services for regulated industries including medical and aerospace sectors. The company operates multiple facilities offering quality assurance and automated inspection capabilities.

1 investor

Equum Medical provides remote monitoring and telehealth staffing services to hospitals and health systems, connecting them with physicians, specialists, nurses, and support staff to address workforce shortages and improve patient care access. The company operates a nationwide network of remote clinical providers serving acute care settings.

1 investor

Escala Medical develops advanced medical devices for pelvic organ prolapse repair, targeting women seeking to restore quality of life. The company specializes in urogynaecological solutions within the broader medical device industry.

1 investor

Esco Aster provides independent technical and investor due diligence services across biotechnology, pharmaceuticals, medical technology, and related life sciences sectors. The company advises venture capital funds, family offices, universities, and other stakeholders on scientific validity, intellectual property, manufacturing, regulatory compliance, and commercial feasibility of life science investments and technologies.

1 investor

Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries. The company operates multiple business units including Esco Scientific for laboratory equipment, Esco Medical for ART/IVF solutions, Esco Healthcare for pharma and biotech support, and Esco Aster as a CDMO offering continuous manufacturing platforms.

1 investor

Esperta Health provides an in-home and virtual wound management program that combines clinical expertise with technology to standardize care and improve healing outcomes. The platform serves patients requiring wound care management across various settings.

1 investor

ESP Management operates specialty eye care practices, providing ocular health and vision services through FDA-approved treatments and technologies. The company emphasizes quality patient care, clinical research, and compliance across its physician-led network.

1 investor

Essential Pharma develops and delivers pharmaceutical medicines for patients in niche populations, with a focus on rare disease, CNS, ophthalmology, and gastroenterology across approximately 70 countries.

1 investor

Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction. The company is founded by experienced ophthalmology and medical device leaders with extensive track records in bringing dry eye treatments to market.

1 investor

Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.

1 investor

Etiometry develops a clinical decision support platform that uses continuous streams of physiologic data to quantify clinical risks for patients in hospital critical care and intensive care units. The company applies AI-based predictive analytics to support clinicians managing critically ill patients.

1 investor

Euclises Pharmaceuticals develops oral, small-molecule drugs targeting COX-2 to disrupt the tumor microenvironment and enhance cancer cell death, particularly when combined with immune checkpoint inhibitors or EGFR inhibitors. The company is advancing these molecules through clinical trials to improve immuno-oncology therapies.

1 investor

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

1 investor

Eurofins Viracor is a clinical laboratory that develops and delivers diagnostic tests for infectious diseases, cellular function disorders, oncology, and transplant rejection monitoring. The company serves healthcare providers and patients in the United States through comprehensive laboratory services and biomarker research.

1 investor

EUROLyser develops diagnostic testing systems and parameters, including a beta-Hydroxybutyrate (BHB) test aimed at veterinarians for measuring ketone bodies. The company operates in the medical/veterinary diagnostics field.

1 investor

Evaheart develops implantable and extracorporeal ventricular assist devices for heart failure and vascular disease treatment. The company manufactures medical devices and operates an integrated ecosystem including research, production, and clinical solutions.

1 investor

Evec (株式会社イーベック) is a Japanese biotechnology company that develops fully human monoclonal antibodies through its research labs. The page is a corporate officers/executive profile page listing the company's board members and auditors.

1 investor

Eveliqure develops a live attenuated vaccine platform for oral administration targeting Shigella and ETEC pathogens that cause diarrheal disease in travelers and populations in low- and middle-income countries. The company's lead product, ShigETEC, provides broad serotype-independent protection against multiple pathogens through targeted genetic mutations.

1 investor

Eventum Orthopaedics develops Quadsense, a medical device that provides real-time intraoperative data to surgeons during total knee arthroplasty procedures, helping optimize patellar positioning and patient outcomes. The company also builds Datasense, a data analysis tool for preoperative, intraoperative, and postoperative decision-making in knee surgery.

1 investor